Cargando…
The effects of pretransportation or arrival meloxicam administration to calves entering the feedlot on morbidity, biomarkers, performance, and carcass characteristics
The objective of this trial was to investigate the effects of using meloxicam as a pretransport or on arrival therapeutic on disease outcomes of bovine respiratory disease (BRD), biomarker outcomes associated with BRD, performance characteristics over the first 42 d on feed, and carcass traits at ha...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200945/ https://www.ncbi.nlm.nih.gov/pubmed/32704832 http://dx.doi.org/10.1093/tas/txz070 |
_version_ | 1783529443347660800 |
---|---|
author | Van Engen, Nicholas K Engelken, Terry J Lockard, Caleb G Lakritz, Jeffery Cernicchiaro, Natalia Wilson, Blake K Krehbiel, Clint R Coetzee, Johann F |
author_facet | Van Engen, Nicholas K Engelken, Terry J Lockard, Caleb G Lakritz, Jeffery Cernicchiaro, Natalia Wilson, Blake K Krehbiel, Clint R Coetzee, Johann F |
author_sort | Van Engen, Nicholas K |
collection | PubMed |
description | The objective of this trial was to investigate the effects of using meloxicam as a pretransport or on arrival therapeutic on disease outcomes of bovine respiratory disease (BRD), biomarker outcomes associated with BRD, performance characteristics over the first 42 d on feed, and carcass traits at harvest in cross bred beef cattle. Multisourced, crossbred steer calves (n = 168) consisting of mainly British and British-Continental breeds were purchased from an auction market in central Missouri. Calves were processed prior to transportation and again upon feedlot arrival. Animals were randomized to 3 separate treatments: pretransport meloxicam (PMEL), arrival meloxicam (AMEL), and a control group receiving inactive excipient (CONT). Dosing at 1 mg/kg on weighted averaged administered per os. Animals were weighed and blood was collected pre- and post-transport. Haptoglobin (Hp)-matrix metaloproteinase (MMP)-9 complex, cortisol, and substance P were quantified. Weights were taken again at 42 d and at harvest. Clinical signs of BRD were monitored using indicators of depression, appetite, respiration, and temperature that qualified the animals for treatment. Harvest parameters were collected using a standardized United States Department of Agriculture grading system for quality grade and yield grade. Meloxicam did not have a significant effect on BRD morbidity over the course of the study and there was no significant effect on performance characteristics at 42 d (P > 0.10). Of the calves that did succumb to BRD, no significant differences were found in severity of disease (P > 0.10). Concentrations of substance P and Hp- MMP-9, were increased on arrival (P ≤ 0.05) however no significant treatment effect or interaction were found between AMEL, PMEL, CONT, or across different levels of biomarkers (P > 0.10). Meloxicam use prior to or on arrival does not mitigate disease or improve performance during the feeding period. |
format | Online Article Text |
id | pubmed-7200945 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-72009452020-07-22 The effects of pretransportation or arrival meloxicam administration to calves entering the feedlot on morbidity, biomarkers, performance, and carcass characteristics Van Engen, Nicholas K Engelken, Terry J Lockard, Caleb G Lakritz, Jeffery Cernicchiaro, Natalia Wilson, Blake K Krehbiel, Clint R Coetzee, Johann F Transl Anim Sci Animal Health And Well Being The objective of this trial was to investigate the effects of using meloxicam as a pretransport or on arrival therapeutic on disease outcomes of bovine respiratory disease (BRD), biomarker outcomes associated with BRD, performance characteristics over the first 42 d on feed, and carcass traits at harvest in cross bred beef cattle. Multisourced, crossbred steer calves (n = 168) consisting of mainly British and British-Continental breeds were purchased from an auction market in central Missouri. Calves were processed prior to transportation and again upon feedlot arrival. Animals were randomized to 3 separate treatments: pretransport meloxicam (PMEL), arrival meloxicam (AMEL), and a control group receiving inactive excipient (CONT). Dosing at 1 mg/kg on weighted averaged administered per os. Animals were weighed and blood was collected pre- and post-transport. Haptoglobin (Hp)-matrix metaloproteinase (MMP)-9 complex, cortisol, and substance P were quantified. Weights were taken again at 42 d and at harvest. Clinical signs of BRD were monitored using indicators of depression, appetite, respiration, and temperature that qualified the animals for treatment. Harvest parameters were collected using a standardized United States Department of Agriculture grading system for quality grade and yield grade. Meloxicam did not have a significant effect on BRD morbidity over the course of the study and there was no significant effect on performance characteristics at 42 d (P > 0.10). Of the calves that did succumb to BRD, no significant differences were found in severity of disease (P > 0.10). Concentrations of substance P and Hp- MMP-9, were increased on arrival (P ≤ 0.05) however no significant treatment effect or interaction were found between AMEL, PMEL, CONT, or across different levels of biomarkers (P > 0.10). Meloxicam use prior to or on arrival does not mitigate disease or improve performance during the feeding period. Oxford University Press 2019-05-13 /pmc/articles/PMC7200945/ /pubmed/32704832 http://dx.doi.org/10.1093/tas/txz070 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of the American Society of Animal Science. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Animal Health And Well Being Van Engen, Nicholas K Engelken, Terry J Lockard, Caleb G Lakritz, Jeffery Cernicchiaro, Natalia Wilson, Blake K Krehbiel, Clint R Coetzee, Johann F The effects of pretransportation or arrival meloxicam administration to calves entering the feedlot on morbidity, biomarkers, performance, and carcass characteristics |
title | The effects of pretransportation or arrival meloxicam administration to calves entering the feedlot on morbidity, biomarkers, performance, and carcass characteristics |
title_full | The effects of pretransportation or arrival meloxicam administration to calves entering the feedlot on morbidity, biomarkers, performance, and carcass characteristics |
title_fullStr | The effects of pretransportation or arrival meloxicam administration to calves entering the feedlot on morbidity, biomarkers, performance, and carcass characteristics |
title_full_unstemmed | The effects of pretransportation or arrival meloxicam administration to calves entering the feedlot on morbidity, biomarkers, performance, and carcass characteristics |
title_short | The effects of pretransportation or arrival meloxicam administration to calves entering the feedlot on morbidity, biomarkers, performance, and carcass characteristics |
title_sort | effects of pretransportation or arrival meloxicam administration to calves entering the feedlot on morbidity, biomarkers, performance, and carcass characteristics |
topic | Animal Health And Well Being |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200945/ https://www.ncbi.nlm.nih.gov/pubmed/32704832 http://dx.doi.org/10.1093/tas/txz070 |
work_keys_str_mv | AT vanengennicholask theeffectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics AT engelkenterryj theeffectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics AT lockardcalebg theeffectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics AT lakritzjeffery theeffectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics AT cernicchiaronatalia theeffectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics AT wilsonblakek theeffectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics AT krehbielclintr theeffectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics AT coetzeejohannf theeffectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics AT vanengennicholask effectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics AT engelkenterryj effectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics AT lockardcalebg effectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics AT lakritzjeffery effectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics AT cernicchiaronatalia effectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics AT wilsonblakek effectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics AT krehbielclintr effectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics AT coetzeejohannf effectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics |